1. Home
  2. CDLX vs RPTX Comparison

CDLX vs RPTX Comparison

Compare CDLX & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDLX
  • RPTX
  • Stock Information
  • Founded
  • CDLX 2008
  • RPTX 2016
  • Country
  • CDLX United States
  • RPTX Canada
  • Employees
  • CDLX N/A
  • RPTX N/A
  • Industry
  • CDLX Computer Software: Programming Data Processing
  • RPTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CDLX Technology
  • RPTX Health Care
  • Exchange
  • CDLX Nasdaq
  • RPTX Nasdaq
  • Market Cap
  • CDLX 190.9M
  • RPTX 155.4M
  • IPO Year
  • CDLX 2018
  • RPTX 2020
  • Fundamental
  • Price
  • CDLX $4.37
  • RPTX $3.59
  • Analyst Decision
  • CDLX Hold
  • RPTX Strong Buy
  • Analyst Count
  • CDLX 6
  • RPTX 1
  • Target Price
  • CDLX $5.90
  • RPTX $10.00
  • AVG Volume (30 Days)
  • CDLX 879.4K
  • RPTX 71.8K
  • Earning Date
  • CDLX 11-06-2024
  • RPTX 11-07-2024
  • Dividend Yield
  • CDLX N/A
  • RPTX N/A
  • EPS Growth
  • CDLX N/A
  • RPTX N/A
  • EPS
  • CDLX N/A
  • RPTX N/A
  • Revenue
  • CDLX $293,468,000.00
  • RPTX $68,683,000.00
  • Revenue This Year
  • CDLX N/A
  • RPTX $16.85
  • Revenue Next Year
  • CDLX $8.09
  • RPTX N/A
  • P/E Ratio
  • CDLX N/A
  • RPTX N/A
  • Revenue Growth
  • CDLX N/A
  • RPTX N/A
  • 52 Week Low
  • CDLX $2.89
  • RPTX $2.71
  • 52 Week High
  • CDLX $20.52
  • RPTX $8.49
  • Technical
  • Relative Strength Index (RSI)
  • CDLX 55.14
  • RPTX 53.00
  • Support Level
  • CDLX $3.53
  • RPTX $3.37
  • Resistance Level
  • CDLX $5.25
  • RPTX $4.05
  • Average True Range (ATR)
  • CDLX 0.35
  • RPTX 0.26
  • MACD
  • CDLX 0.05
  • RPTX 0.00
  • Stochastic Oscillator
  • CDLX 48.98
  • RPTX 40.65

About CDLX Cardlytics Inc.

Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

Share on Social Networks: